POC
Point of care analysis
True Diagnosis
Reduce risks of false negatives
Fast Results
Results within 75 minutes
For a better diagnostic of
Lyme Disease
About Lyme Disease
Patients with Lyme disease are found in over 80 countries and the number of new infections is growing 25% annually. In the US, the Center for Disease Control (CDC) estimates that 478 000 Americans were infected in 2020. In Canda, there was 2.7 cases per 100,000 population in 2016. It seems more than 50% of the patients tested for Lyme disease generated a false negative result.
A challenging Diagnostic
A potential cause for such results could be the lack of consideration for the multiple co-infections (50+) related to the current diagnostic tests for LD. Indeed, these tests only frame the bacteria Borrelia burgdorferi, which seems to become undetectable a few weeks after the initial infection.
What we develop
An unrivaled diagnostic tool
Raspberry Scientific develops a multiplex serological test detecting Borrelia burgdorferi, along with more than 25 known co-infections of Lyme disease. This assay is based on our revolutionary technology aiming at analyzing the full spectrum of a patient’s immune response, at point of care, within 75 minutes.